Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, western clawed |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Fibroleukin, also known as fibrinogen-like protein 2 (fgl2) is a prothrombinase []that appears to play an important role in innate immunity []. It has been linked to allograft rejection []and correlated with severity of chronic hepatitis C virus infection []. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
432
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Ning Q |
Year: |
2005 |
Journal: |
J Immunol |
Title: |
Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection. |
Volume: |
174 |
Issue: |
11 |
Pages: |
7403-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang L |
Year: |
2023 |
Journal: |
Front Immunol |
Title: |
FGL2 deficiency alleviates maternal inflammation-induced blood-brain barrier damage by blocking PI3K/NF-κB mediated endothelial oxidative stress. |
Volume: |
14 |
|
Pages: |
1157027 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mu J |
Year: |
2007 |
Journal: |
Physiol Genomics |
Title: |
Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in mice. |
Volume: |
31 |
Issue: |
1 |
Pages: |
53-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Clark DA |
Year: |
2004 |
Journal: |
Mol Hum Reprod |
Title: |
The fgl2 prothrombinase/fibroleukin gene is required for lipopolysaccharide-triggered abortions and for normal mouse reproduction. |
Volume: |
10 |
Issue: |
2 |
Pages: |
99-108 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shalev I |
Year: |
2008 |
Journal: |
J Immunol |
Title: |
Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis. |
Volume: |
180 |
Issue: |
1 |
Pages: |
249-60 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bennion KB |
Year: |
2024 |
Journal: |
Nat Commun |
Title: |
CD8(+) T cell-derived Fgl2 regulates immunity in a cell-autonomous manner via ligation of FcγRIIB. |
Volume: |
15 |
Issue: |
1 |
Pages: |
5280 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ning Q |
Year: |
1999 |
Journal: |
J Biol Chem |
Title: |
The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene. |
Volume: |
274 |
Issue: |
15 |
Pages: |
9930-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Galpin KJC |
Year: |
2024 |
Journal: |
Sci Rep |
Title: |
FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models. |
Volume: |
14 |
Issue: |
1 |
Pages: |
787 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li T |
Year: |
2020 |
Journal: |
Mol Immunol |
Title: |
FGL2 regulates IKK/NF-κB signaling in intestinal epithelial cells and lamina propria dendritic cells to attenuate dextran sulfate sodium-induced colitis. |
Volume: |
117 |
|
Pages: |
84-93 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6172909 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689419 |
Pattern: |
Not Specified |
Stage: |
TS19 |
Assay Id: |
MGI:6190282 |
Age: |
embryonic day 11.5 |
|
|
Specimen Label: |
Table S2 - E11.5 - Fgl2 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6172909 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689421 |
Pattern: |
Not Specified |
Stage: |
TS21 |
Assay Id: |
MGI:6190282 |
Age: |
embryonic day 13.5 |
|
|
Specimen Label: |
Table S2 - E13.5 - Fgl2 |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6172909 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689426 |
Pattern: |
Not Specified |
Stage: |
TS26 |
Assay Id: |
MGI:6190282 |
Age: |
embryonic day 18.5 |
|
|
Specimen Label: |
Table S2 - E18.5 - Fgl2 |
Detected: |
true |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6172909 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:6190282 |
Age: |
postnatal day 4 |
|
|
Specimen Label: |
Table S2 - P4 - Fgl2 |
Detected: |
true |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6172909 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:6190282 |
Age: |
postnatal day 28 |
|
|
Specimen Label: |
Table S2 - P28 - Fgl2 |
Detected: |
true |
Specimen Num: |
7 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6172909 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689424 |
Pattern: |
Not Specified |
Stage: |
TS24 |
Assay Id: |
MGI:6190282 |
Age: |
embryonic day 15.5 |
|
|
Specimen Label: |
Table S2 - E15.5 - Fgl2 |
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6172909 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:6190282 |
Age: |
postnatal day 14 |
|
|
Specimen Label: |
Table S2 - P14 - Fgl2 |
Detected: |
true |
Specimen Num: |
6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Khattar R |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE. |
Volume: |
8 |
Issue: |
10 |
Pages: |
e72309 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
432
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Chan CW |
Year: |
2003 |
Journal: |
J Immunol |
Title: |
Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. |
Volume: |
170 |
Issue: |
8 |
Pages: |
4036-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Foerster K |
Year: |
2010 |
Journal: |
J Hepatol |
Title: |
The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection. |
Volume: |
53 |
Issue: |
4 |
Pages: |
608-15 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chan CW |
Year: |
2002 |
Journal: |
J Immunol |
Title: |
Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity. |
Volume: |
168 |
Issue: |
10 |
Pages: |
5170-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu J |
Year: |
2020 |
Journal: |
Theranostics |
Title: |
Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder. |
Volume: |
10 |
Issue: |
21 |
Pages: |
9702-9720 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhu Y |
Year: |
2018 |
Journal: |
Front Immunol |
Title: |
Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2. |
Volume: |
9 |
|
Pages: |
87 |
|
•
•
•
•
•
|
Publication |
First Author: |
Luft O |
Year: |
2018 |
Journal: |
Immunology |
Title: |
Inhibition of the Fibrinogen-Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13. |
Volume: |
154 |
Issue: |
3 |
Pages: |
476-489 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bartczak A |
Year: |
2017 |
Journal: |
World J Gastroenterol |
Title: |
Overexpression of fibrinogen-like protein 2 protects against T cell-induced colitis. |
Volume: |
23 |
Issue: |
15 |
Pages: |
2673-2684 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bartczak A |
Year: |
2016 |
Journal: |
Am J Transplant |
Title: |
Overexpression of Fibrinogen-Like Protein 2 Promotes Tolerance in a Fully Mismatched Murine Model of Heart Transplantation. |
Volume: |
16 |
Issue: |
6 |
Pages: |
1739-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yuwaraj S |
Year: |
2001 |
Journal: |
Genomics |
Title: |
Genomic characterization, localization, and functional expression of FGL2, the human gene encoding fibroleukin: a novel human procoagulant. |
Volume: |
71 |
Issue: |
3 |
Pages: |
330-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu S |
Year: |
2020 |
Journal: |
Biomed Pharmacother |
Title: |
Fibrinogen-like protein 2 deficiency aggravates renal fibrosis by facilitating macrophage polarization. |
Volume: |
130 |
|
Pages: |
110468 |
|
•
•
•
•
•
|
Publication |
First Author: |
Foerster K |
Year: |
2007 |
Journal: |
Am J Reprod Immunol |
Title: |
LPS-induced occult loss in mice requires FGL2. |
Volume: |
58 |
Issue: |
6 |
Pages: |
524-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang J |
Year: |
2015 |
Journal: |
PLoS Negl Trop Dis |
Title: |
Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice. |
Volume: |
9 |
Issue: |
5 |
Pages: |
e0003755 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu X |
Year: |
2023 |
Journal: |
Int Immunopharmacol |
Title: |
Fibrinogen-like protein 2 regulates macrophage glycolytic reprogramming by directly targeting PKM2 and exacerbates alcoholic liver injury. |
Volume: |
124 |
Issue: |
Pt B |
Pages: |
110957 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen Q |
Year: |
2022 |
Journal: |
Cell Rep |
Title: |
Development of allergen-specific IgE in a food-allergy model requires precisely timed B cell stimulation and is inhibited by Fgl2. |
Volume: |
39 |
Issue: |
13 |
Pages: |
110990 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fu Y |
Year: |
2020 |
Journal: |
Sci Adv |
Title: |
Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2. |
Volume: |
6 |
Issue: |
9 |
Pages: |
eaay9269 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu H |
Year: |
2008 |
Journal: |
Eur J Immunol |
Title: |
The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression. |
Volume: |
38 |
Issue: |
11 |
Pages: |
3114-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sungnak W |
Year: |
2020 |
Journal: |
J Immunol |
Title: |
T Follicular Regulatory Cell-Derived Fibrinogen-like Protein 2 Regulates Production of Autoantibodies and Induction of Systemic Autoimmunity. |
Volume: |
205 |
Issue: |
12 |
Pages: |
3247-3262 |
|
•
•
•
•
•
|
Publication |
First Author: |
Joller N |
Year: |
2014 |
Journal: |
Immunity |
Title: |
Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. |
Volume: |
40 |
Issue: |
4 |
Pages: |
569-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu GL |
Year: |
2014 |
Journal: |
Hepatology |
Title: |
C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression. |
Volume: |
60 |
Issue: |
1 |
Pages: |
114-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yu H |
Year: |
2018 |
Journal: |
Front Immunol |
Title: |
Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression. |
Volume: |
9 |
|
Pages: |
2935 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hancock WW |
Year: |
2004 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2. |
Volume: |
101 |
Issue: |
9 |
Pages: |
3005-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu M |
Year: |
2006 |
Journal: |
J Immunol |
Title: |
Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements. |
Volume: |
176 |
Issue: |
11 |
Pages: |
7028-38 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus caroli |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus pahari |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus spretus |
|
•
•
•
•
•
|
Publication |
First Author: |
Koyama T |
Year: |
1987 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains. |
Volume: |
84 |
Issue: |
6 |
Pages: |
1609-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Marsden PA |
Year: |
2003 |
Journal: |
J Clin Invest |
Title: |
The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. |
Volume: |
112 |
Issue: |
1 |
Pages: |
58-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mendicino M |
Year: |
2005 |
Journal: |
Circulation |
Title: |
Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts. |
Volume: |
112 |
Issue: |
2 |
Pages: |
248-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lafuse WP |
Year: |
1995 |
Journal: |
Cell Immunol |
Title: |
The cytotoxic T lymphocyte gene FIBLP with homology to fibrinogen beta and gamma subunits is also induced in mouse macrophages by IFN-gamma. |
Volume: |
163 |
Issue: |
2 |
Pages: |
187-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qureshi ST |
Year: |
1995 |
Journal: |
Genomics |
Title: |
Mouse hepatitis virus-3 induced prothrombinase (Fgl2) maps to proximal chromosome 5. |
Volume: |
29 |
Issue: |
1 |
Pages: |
307-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rychlik DF |
Year: |
2003 |
Journal: |
J Soc Gynecol Investig |
Title: |
Cloning and tissue expression of the tissue prothrombinase Fgl-2 in the Sprague-Dawley rat. |
Volume: |
10 |
Issue: |
2 |
Pages: |
67-73 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7543819 |
Assay Type: |
RT-PCR |
Annotation Date: |
2023-11-20 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1610528 |
|
Stage: |
TS28 |
Assay Id: |
MGI:7549386 |
Age: |
postnatal week 10 |
Image: |
1 |
|
Specimen Label: |
Heart |
Detected: |
false |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7543819 |
Assay Type: |
RT-PCR |
Annotation Date: |
2023-11-20 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1672828 |
|
Stage: |
TS28 |
Assay Id: |
MGI:7549386 |
Age: |
postnatal week 10 |
Image: |
1 |
|
Specimen Label: |
Lung |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7543819 |
Assay Type: |
RT-PCR |
Annotation Date: |
2023-11-20 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1684628 |
|
Stage: |
TS28 |
Assay Id: |
MGI:7549386 |
Age: |
postnatal week 10 |
Image: |
1 |
|
Specimen Label: |
Liver |
Detected: |
false |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7543819 |
Assay Type: |
RT-PCR |
Annotation Date: |
2023-11-20 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1737328 |
|
Stage: |
TS28 |
Assay Id: |
MGI:7549386 |
Age: |
postnatal week 10 |
Image: |
1 |
|
Specimen Label: |
Kidney |
Detected: |
false |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7543819 |
Assay Type: |
RT-PCR |
Annotation Date: |
2023-11-20 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1876728 |
|
Stage: |
TS28 |
Assay Id: |
MGI:7549386 |
Age: |
postnatal week 10 |
Image: |
1 |
|
Specimen Label: |
Spleen |
Detected: |
true |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7543819 |
Assay Type: |
RT-PCR |
Annotation Date: |
2023-11-20 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3511228 |
|
Stage: |
TS28 |
Assay Id: |
MGI:7549386 |
Age: |
postnatal week 10 |
Image: |
1 |
|
Specimen Label: |
Fat |
Detected: |
true |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7543819 |
Assay Type: |
RT-PCR |
Annotation Date: |
2023-11-20 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689428 |
|
Stage: |
TS28 |
Assay Id: |
MGI:7549386 |
Age: |
postnatal week 10 |
Image: |
1 |
|
Specimen Label: |
Brain |
Detected: |
false |
Specimen Num: |
7 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7543819 |
Assay Type: |
RT-PCR |
Annotation Date: |
2023-11-20 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1914328 |
|
Stage: |
TS28 |
Assay Id: |
MGI:7549386 |
Age: |
postnatal week 10 |
Image: |
1 |
|
Specimen Label: |
Femur |
Detected: |
true |
Specimen Num: |
8 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7543819 |
Assay Type: |
RT-PCR |
Annotation Date: |
2023-11-20 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1768128 |
|
Stage: |
TS28 |
Assay Id: |
MGI:7549386 |
Age: |
postnatal week 10 |
Image: |
1 |
|
Specimen Label: |
Calvaria |
Detected: |
true |
Specimen Num: |
9 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:1552015 |
Assay Type: |
RNA in situ |
Annotation Date: |
2011-11-09 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1616517 |
Pattern: |
Not Specified |
Stage: |
TS17 |
Assay Id: |
MGI:5295396 |
Age: |
embryonic day 10.5 |
Image: |
S1 |
|
Specimen Label: |
S1 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3568928 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 10.5 |
|
Note: |
Expression is in the placental labyrinthine and spongiotrophoblasts. |
Specimen Label: |
3B |
Detected: |
true |
Specimen Num: |
16 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3568928 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 10.5 |
|
Note: |
Expression is in the placental labyrinthine and spongiotrophoblasts. |
Specimen Label: |
3D |
Detected: |
true |
Specimen Num: |
17 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3568928 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 11.5 |
|
Note: |
Expression is in the placental labyrinthine and spongiotrophoblasts. |
Specimen Label: |
3F |
Detected: |
true |
Specimen Num: |
18 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3568928 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 11.5 |
|
Note: |
Expression is in the placental labyrinthine and spongiotrophoblasts. |
Specimen Label: |
3H |
Detected: |
true |
Specimen Num: |
19 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3568928 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 12.5 |
|
Note: |
Expression is in the placental labyrinthine and spongiotrophoblasts. |
Specimen Label: |
3J |
Detected: |
true |
Specimen Num: |
20 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3568928 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 12.5 |
|
Note: |
Expression is in the placental labyrinthine and spongiotrophoblasts. |
Specimen Label: |
3L |
Detected: |
true |
Specimen Num: |
21 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3568928 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 13.5 |
|
Note: |
Expression is in the placental labyrinthine and spongiotrophoblasts. |
Specimen Label: |
4B |
Detected: |
true |
Specimen Num: |
22 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3568928 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 13.5 |
|
Note: |
Expression is in the placental labyrinthine and spongiotrophoblasts. |
Specimen Label: |
4D |
Detected: |
true |
Specimen Num: |
23 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1640521 |
Pattern: |
Not Specified |
Stage: |
TS21 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 13.5 |
|
|
Specimen Label: |
4F |
Detected: |
true |
Specimen Num: |
24 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Very strong |
Sex: |
Not Specified |
Emaps: |
EMAPS:3526928 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 5.5 |
|
|
Specimen Label: |
1B (decidua) |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Very strong |
Sex: |
Not Specified |
Emaps: |
EMAPS:3526928 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 5.5 |
|
|
Specimen Label: |
1D |
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3526928 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 7.5 |
|
Note: |
There is a zone of non-staining decidua at the maternal/fetal trophoblast interface. |
Specimen Label: |
1J |
Detected: |
true |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3526928 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 7.5 |
|
Note: |
There is a zone of non-staining decidua at the maternal/fetal trophoblast interface. |
Specimen Label: |
1L |
Detected: |
true |
Specimen Num: |
7 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3759440 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2007-10-28 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3526928 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:3759442 |
Age: |
embryonic day 8.5 |
|
Note: |
Staining of decidua was more clearly separated from that of embryonic trophoblasts. |
Specimen Label: |
2B |
Detected: |
true |
Specimen Num: |
8 |
|
•
•
•
•
•
|